Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 6Unknown 2Recruiting 2Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2

Conditions

Carcinoma, Non-Small-Cell Lung 431Breast Neoplasms 300Neoplasms 297Colorectal Neoplasms 245Neoplasm Metastasis 193Ovarian Neoplasms 173Lung Neoplasms 151Prostatic Neoplasms 149Recurrence 147Pancreatic Neoplasms 143Multiple Myeloma 134Stomach Neoplasms 130Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Endometrial Neoplasms 119Leukemia, Myeloid, Acute 114Advanced Solid Tumors 113Advanced Solid Tumor 111Triple Negative Breast Neoplasms 103Carcinoma, Hepatocellular 102Uterine Cervical Neoplasms 90Small Cell Lung Carcinoma 88Lymphoma, Non-Hodgkin 84Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Esophageal Neoplasms 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Blood Protein Disorders × Clear all
NCT07075185 2026-04-24

inMMyCAR

Kelonia Therapeutics, Inc.

Phase 1 Recruiting
70 enrolled
LymphoidPlasma cell

Blood Protein Disorders, Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT06271252 2024-08-02

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

OriCell Therapeutics Co., Ltd.

Phase 1 Recruiting
81 enrolled
LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡